1.
Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1.
Markets Covered
1.2.2.
Years Considered for
Study
1.2.3.
Key Market
Segmentations
2.
Research Methodology
2.1.
Objective of the study
2.2.
Baseline methodology
2.3.
Key industry partners
2.4.
Major association and secondary sources
2.5.
Forecasting methodology
2.6.
Data triangulation & validation
2.7.
Assumptions and limitations
3.
Impact Of Covid-19 On Global Emerging Infectious Disease
Diagnostics Market
4.
Executive Summary
4.1. Overview of the market
4.2. Overview of key market segmentations
4.3. Overview of key market players
4.4. Overview of key regions/countries
4.5. Overview of market drivers, challenges, trends
5.
Voice of Customer
6.
Global Emerging Infectious Disease Diagnostics Market
Outlook
6.1.
Market Size &
Forecast
6.1.1. By Value
6.2.
Market Share &
Forecast
6.2.1.
By Application (Laboratory Testing and Point of Care
Testing)
6.2.2.
By Technology (Polymerase Chain Reaction,
Immunodiagnostics, Isothermal Nucleic Acid Amplification Technology (INAAT),
Next-Generation Sequencing (NGS), And Others)
6.2.3.
By Type of Infection (Bacterial, Viral, Fungal, and
Others)
6.2.4.
By Disease Type (Respiratory Infections, Gastrointestinal
Infections, Sexually Transmitted Infections (STIs), and Others)
6.2.5.
By End User (Hospitals & Clinics, Diagnostic
laboratories, and Others)
6.2.6. By Region
6.2.7. By Company (2023)
6.3.
Market Map
7.
North America
Emerging Infectious Disease Diagnostics Market Outlook
7.1.
Market Size &
Forecast
7.1.1.
By Value
7.2.
Market Share &
Forecast
7.2.1. By Application
7.2.2.
By Technology
7.2.3.
By Type of Infection
7.2.4.
By Disease Type
7.2.5.
By End user
7.2.6. By
Country
7.3.
North America:
Country Analysis
7.3.1.
United States
Emerging Infectious Disease Diagnostics Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Application
7.3.1.2.2.
By Technology
7.3.1.2.3.
By Type of Infection
7.3.1.2.4.
By Disease type
7.3.1.2.5.
By End user
7.3.2.
Canada Emerging Infectious
Disease Diagnostics Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Application
7.3.2.2.2.
By Technology
7.3.2.2.3.
By Type of Infection
7.3.2.2.4.
By Disease type
7.3.2.2.5.
By End user
7.3.3.
Mexico Emerging
Infectious Disease Diagnostics Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Application
7.3.3.2.2.
By Technology
7.3.3.2.3.
By Type of Infection
7.3.3.2.4.
By Disease type
7.3.3.2.5.
By End user
8. Europe Emerging Infectious Disease Diagnostics
Outlook
8.1.
Market Size &
Forecast
8.1.1.
By Value
8.2.
Market Share &
Forecast
8.2.1.
By Application
8.2.2.
By Technology
8.2.3.
By Type of Infection
8.2.4.
By Disease Type
8.2.5.
By End user
8.2.6.
By Country
8.3.
Europe: Country
Analysis
8.3.1.
Germany Emerging
Infectious Disease Diagnostics Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Application
8.3.1.2.2.
By Technology
8.3.1.2.3.
By Type of Infection
8.3.1.2.4.
By Disease type
8.3.1.2.5.
By End user
8.3.2.
Italy Emerging
Infectious Disease Diagnostics Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Application
8.3.2.2.2.
By Technology
8.3.2.2.3.
By Type of Infection
8.3.2.2.4.
By Disease type
8.3.2.2.5.
By End user
8.3.3.
France Emerging
Infectious Disease Diagnostics Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Application
8.3.3.2.2.
By Technology
8.3.3.2.3.
By Type of Infection
8.3.3.2.4.
By Disease type
8.3.3.2.5.
By End user
8.3.4.
Spain Emerging
Infectious Disease Diagnostics Market Outlook
8.3.4.1.
Market Size & Forecast
8.3.4.1.1.
By Value
8.3.4.2.
Market Share & Forecast
8.3.4.2.1.
By Application
8.3.4.2.2.
By Technology
8.3.4.2.3.
By Type of Infection
8.3.4.2.4.
By Disease type
8.3.4.2.5.
By End user
8.3.5.
United Kingdom
Emerging Infectious Disease Diagnostics Market Outlook
8.3.5.1.
Market Size & Forecast
8.3.5.1.1.
By Value
8.3.5.2.
Market Share & Forecast
8.3.5.2.1.
By Application
8.3.5.2.2.
By Technology
8.3.5.2.3.
By Type of Infection
8.3.5.2.4.
By Disease type
8.3.5.2.5.
By End user
9. Asia-Pacific Emerging Infectious Disease
Diagnostics Market Outlook
9.1.
Market Size &
Forecast
9.1.1.
By Value
9.2.
Market Share &
Forecast
9.2.1.
By Application
9.2.2.
By Technology
9.2.3.
By Type of Infection
9.2.4.
By Disease Type
9.2.5.
By End user
9.2.6.
By Country
9.3.
Asia Pacific:
Country Analysis
9.3.1.
China Emerging
Infectious Disease Diagnostics Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Application
9.3.1.2.2.
By Technology
9.3.1.2.3.
By Type of Infection
9.3.1.2.4.
By Disease type
9.3.1.2.5.
By End user
9.3.2.
Japan Emerging
Infectious Disease Diagnostics Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Application
9.3.2.2.2.
By Technology
9.3.2.2.3.
By Type of Infection
9.3.2.2.4.
By Disease type
9.3.2.2.5.
By End user
9.3.3.
India Emerging
Infectious Disease Diagnostics Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Application
9.3.3.2.2.
By Technology
9.3.3.2.3.
By Type of Infection
9.3.3.2.4.
By Disease type
9.3.3.2.5.
By End user
9.3.4.
Australia Emerging Infectious
Disease Diagnostics Market Outlook
9.3.4.1.
Market Size & Forecast
9.3.4.1.1.
By Value
9.3.4.2.
Market Share & Forecast
9.3.4.2.1.
By Application
9.3.4.2.2.
By Technology
9.3.4.2.3.
By Type of Infection
9.3.4.2.4.
By Disease type
9.3.4.2.5.
By End user
9.3.5.
South Korea Emerging
Infectious Disease Diagnostics Market Outlook
9.3.5.1.
Market Size & Forecast
9.3.5.1.1.
By Value
9.3.5.2.
Market Share & Forecast
9.3.5.2.1.
By Application
9.3.5.2.2.
By Technology
9.3.5.2.3.
By Type of Infection
9.3.5.2.4.
By Disease type
9.3.5.2.5.
By End user
10. Middle East and Africa Emerging Infectious
Disease Diagnostics Market Outlook
10.1.
Market Size & Forecast
10.1.1.
By Value
10.2.
Market Share &
Forecast
10.2.1.
By Application
10.2.2.
By Technology
10.2.3.
By Type of Infection
10.2.4.
By Disease Type
10.2.5.
By End user
10.2.6.
By Country
10.3.
Middle East and
Africa: Country Analysis
10.3.1.
UAE Emerging
Infectious Disease Diagnostics Market Outlook
10.3.1.1.
Market Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2.
Market Share & Forecast
10.3.1.2.1.
By Application
10.3.1.2.2.
By Technology
10.3.1.2.3.
By Type of Infection
10.3.1.2.4.
By Disease type
10.3.1.2.5.
By End user
10.3.2.
Saudi Arabia
Emerging Infectious Disease Diagnostics Market Outlook
10.3.2.1.
Market Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2.
Market Share & Forecast
10.3.2.2.1.
By Application
10.3.2.2.2.
By Technology
10.3.2.2.3.
By Type of Infection
10.3.2.2.4.
By Disease type
10.3.2.2.5.
By End user
10.3.3.
South Africa
Emerging Infectious Disease Diagnostics Market Outlook
10.3.3.1.
Market Size & Forecast
10.3.3.1.1.
By Value
10.3.3.2.
Market Share & Forecast
10.3.3.2.1.
By Application
10.3.3.2.2.
By Technology
10.3.3.2.3.
By Type of Infection
10.3.3.2.4.
By Disease type
10.3.3.2.5.
By End user
11. South America Emerging Infectious Disease
Diagnostics Market Outlook
11.1.
Market Size &
Forecast
11.1.1.
By Value
11.2.
Market Share &
Forecast
11.2.1.
By Application
11.2.2.
By Technology
11.2.3.
By Type of Infection
11.2.4.
By Disease Type
11.2.5.
By End user
11.2.6.
By Country
11.3.
South America:
Country Analysis
11.3.1.
Brazil Emerging
Infectious Disease Diagnostics Market Outlook
11.3.1.1.
Market Size & Forecast
11.3.1.1.1.
By Value
11.3.1.2.
Market Share & Forecast
11.3.1.2.1.
By Application
11.3.1.2.2.
By Technology
11.3.1.2.3.
By Type of Infection
11.3.1.2.4.
By Disease type
11.3.1.2.5.
By End user
11.3.2.
Argentina Emerging
Infectious Disease Diagnostics Market Outlook
11.3.2.1.
Market Size & Forecast
11.3.2.1.1.
By Value
11.3.2.2.
Market Share & Forecast
11.3.2.2.1.
By Application
11.3.2.2.2.
By Technology
11.3.2.2.3.
By Type of Infection
11.3.2.2.4.
By Disease type
11.3.2.2.5.
By End user
11.3.3.
Colombia Emerging
Infectious Disease Diagnostics Market Outlook
11.3.3.1.
Market Size & Forecast
11.3.3.1.1.
By Value
11.3.3.2.
Market Share & Forecast
11.3.3.2.1.
By Application
11.3.3.2.2.
By Technology
11.3.3.2.3.
By Type of Infection
11.3.3.2.4.
By Disease type
11.3.3.2.5.
By End user
12.
Market Dynamics
12.1.
Drivers
12.2.
Challenges
13.
Market Trends &
Developments
13.1.
Merger &
Acquisition (If Any)
13.2.
Product Launches (If
Any)
13.3.
Recent Developments
14.
Global Emerging Infectious Disease Diagnostics Market:
SWOT Analysis
15.
Porter’s Five Forces Analysis
15.1.
Competition in the
Industry
15.2.
Potential of New
Entrants
15.3.
Power of Suppliers
15.4.
Power of Customers
15.5.
Threat of Substitute
Products
16.
Competitive
Landscape
16.1.
BioMérieux SA
16.1.1. Business Overview
16.1.2. Company Snapshot
16.1.3. Products & Services
16.1.4. Financials (As Reported)
16.1.5. Recent Developments
16.1.6. Key Personnel Details
16.1.7. SWOT Analysis
16.2.
Bio-Rad Laboratories, Inc.
16.3.
Becton Dickinson & Company
16.4.
Agilent Technologies, Inc.
16.5.
Abbott Laboratories Inc
16.6.
Thermo Fisher Scientific Inc
16.7.
Roche Diagnostics Corporation
16.8.
DiaSorin SpA
16.9.
F. Hoffmann-La Roche Ltd.
16.10.
Danaher Corporation
17.
Strategic Recommendations
18.
About Us & Disclaimer